Remus Pharmaceuticals Limited — Others, 22-05-2025: Copy of Newspaper Publication

Remus Pharmaceuticals has announced a board meeting to consider the financial results for the quarter and half-year. The company has completed dispatching the postal ballot notice and started e-voting, enabling shareholders to participate remotely. This move ensures smooth shareholder engagement and supports transparent decision-making on key corporate matters.